Oxford Biotherapeutics
- Biotech or pharma, therapeutic R&D
OBT is a clinical stage oncology company with a pipeline of first-in-class antibody-based therapies. OBT utilizes OGAP-Verify its proprietary proteomic target discovery platform for ADC, CAR-T and bispecific novel target discovery.
Address
OxfordAbingdon
United Kingdom
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}